2
Announcements
Trials
Browse
Landscape
Status
Completed
2
Unknown
1
Sponsor Class
OTHER_GOV
1
OTHER
1
INDUSTRY
1
Study Type
Observational
3
Sponsor
Cancer Type
Gastrointestinal
80
Thoracic
13
Breast
9
Gynecologic
8
NET
6
Endocrine
6
Head & Neck
5
Genitourinary
5
Dermatologic
5
Classical hematology
3
Sarcoma
2
Lymphoid
2
CNS
2
Plasma cell
1
Other solid neoplasm
1
Other neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Conditions
Anemia, Refractory, with Excess of Blasts
271
Leukemia, Myeloid, Acute
258
Myelodysplastic Syndromes
254
Anemia
245
Leukemia
228
Neoplasms
211
Precursor Cell Lymphoblastic Leukemia-Lymphoma
182
Leukemia, Myelomonocytic, Chronic
151
Multiple Myeloma
138
Venous Thromboembolism
136
Myeloproliferative Disorders
131
Leukemia, Lymphocytic, Chronic, B-Cell
126
Lymphoma
119
Lymphoma, Non-Hodgkin
118
Thrombocytopenia
117
Hodgkin Disease
103
Anemia, Aplastic
97
Febrile Neutropenia
86
Hematologic Neoplasms
82
Anemia, Refractory
82
Primary Myelofibrosis
81
Lymphoma, Follicular
81
Congenital Abnormalities
81
Leukemia, Myeloid, Chronic-Phase
74
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
73
Blast Crisis
72
Leukemia, Myeloid, Accelerated Phase
69
Lymphoma, Mantle-Cell
68
Neoplasms, Plasma Cell
66
Myelodysplastic-Myeloproliferative Diseases
65
Interventions
Tinzaparin
1
Endoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Intestinal Neoplasms
×
Classical hematology
×
Clear all
NCT04744688
2024-05-29
CONTEST
University of Aarhus
Completed
90 enrolled
NCT06219395
2024-01-23
WCE-IDA
Vastra Gotaland Region
Unknown
100 enrolled
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled